Your Health, We Care
The most common adverse reactions (≥20%) in patients with multiplemyeloma who receive XVd are fatigue, nausea, decreased appetite,diarrhea, peripheral neuropathy, upper respiratory tract infection,weight decreased, cataract, and vomiting.
from FDA，2022.07
